Trustees Of Columbia University In The City Of New York Vor Biopharma Inc. Transaction History
Trustees Of Columbia University In The City Of New York
- $689 Million
- Q2 2025
A detailed history of Trustees Of Columbia University In The City Of New York transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Trustees Of Columbia University In The City Of New York holds 91,910 shares of VOR stock, worth $2.59 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
91,910
Previous 91,910
-0.0%
Holding current value
$2.59 Million
Previous $66,000
124.24%
% of portfolio
0.02%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding VOR
# of Institutions
43Shares Held
55.7MCall Options Held
4.15MPut Options Held
364K-
Ra Capital Management, L.P. Boston, MA39.6MShares$1.12 Billion1.4% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$179 Million6.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$53.9 Million0.0% of portfolio
-
Ubs Group Ag1.53MShares$43.1 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$30.3 Million0.59% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $1.07B
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...